Your session is about to expire
← Back to Search
pericapsular nerve group block and lateral femoral cutaneous nerve block for Pain relief (PengvsFICB Trial)
PengvsFICB Trial Summary
This trial tests which of 2 interventions for pain control during hip arthroplasty is better. One is newer and not well known.
PengvsFICB Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPengvsFICB Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PengvsFICB Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many participants are taking part in this research?
"Indeed, the information on clinicaltrials.gov confirms that this medical study is actively seeking participants. This trial was posted to the site on July 28th 2022 and has since been updated; currently 105 individuals need to be enrolled from 1 location."
Is the minimum age requirement for this trial below 20 years?
"This research trial is including individuals aged 40 and over, with a maximum age of 80."
Who is the optimal cohort for this scientific examination?
"This medical trial is currently seeking 105 participants in the 40-80 age range who suffer from analgesia. Aside from this, these patients must also meet further eligibility requirements such as a BMI lower than 40 kg/m2 and fluency in English to sign their own consent form and undergo elective primary total hip arthroplasty."
Are there still vacancies in this experiment for participants?
"Data hosted on clinicaltrials.gov verifies that this research study, which was initially posted on July 28th 2022, is actively recruiting patients. The most recent update occurred on the same date as its posting."
Share this study with friends
Copy Link
Messenger